Cauê Benito Scarim (Cauê B Scarim)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Trypanosoma Cruzi

Top Venues

Nanomedicine (London, England)

Drug development research

Current medicinal chemistry

Medicinal chemistry (Shariqah (United Arab Emirates))

This page only lists publications with an associated author ORCID identifier.

Publications

Aline de Souza, Cauê Benito Scarim, Paulo Cesar Cotrim, Fernando Barbosa Junior, Bruno Alves Rocha, Leandro Augusto Calixto, Cristiano de Jesus Correia, Gabriel Lima Barros de Araujo, Raimar Löbenberg, Nádia Araci Bou-Chacra, Ana Cristina Breithaupt-Faloppa
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine (London, England) 19 (4) (2024)
Aline de Souza, Cauê Benito Scarim, Paulo Cesar Cotrim, Fernando Barbosa Junior, Bruno Alves Rocha, Leandro Augusto Calixto, Cristiano de Jesus Correia, Gabriel Lima Barros de Araujo, Raimar Löbenberg, Nádia Araci Bou-Chacra, Ana Cristina Breithaupt-Faloppa
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine (London, England) 19 (4) (2024)
Ivone Leila Lima Delgado, Cauê Benito Scarim, Felipe Hugo Alencar Fernandes, Karina Pereira Barbieri, Marisa Campos Polesi, Aline Renata Pavan, Diego Eidy Chiba, Hérida Regina Nunes Salgado, Iracilda Zeppone Carlos, Marcos Antonio Corrêa, Cleverton Roberto de Andrade, Jean Leandro Dos Santos
In vitro and In vivo Activity of a New N-Oxide Derivative for Acne Vulgaris Treatment. Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
Aline de Souza, Cauê Benito Scarim, Paulo Cesar Cotrim, Fernando Barbosa Junior, Bruno Alves Rocha, Leandro Augusto Calixto, Cristiano de Jesus Correia, Gabriel Lima Barros de Araujo, Raimar Löbenberg, Nádia Araci Bou-Chacra, Ana Cristina Breithaupt-Faloppa
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine (London, England) (2024)
Aline de Souza, Cauê Benito Scarim, Paulo Cesar Cotrim, Fernando Barbosa Junior, Bruno Alves Rocha, Leandro Augusto Calixto, Cristiano de Jesus Correia, Gabriel Lima Barros de Araujo, Raimar Löbenberg, Nádia Araci Bou-Chacra, Ana Cristina Breithaupt-Faloppa
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine (London, England) 19 (4) (2024)
Guilherme Felipe Dos Santos Fernandes, Juliana R Lopes, Jean Leandro Dos Santos, Cauê Benito Scarim
Phthalimide as a versatile pharmacophore scaffold: Unlocking its diverse biological activities. Drug development research (2023)
João Lucas Bruno Prates, Juliana Romano Lopes, Chung Man Chin, Elizabeth Igne Ferreira, Jean Leandro Dos Santos, Cauê Benito Scarim
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruz. Current medicinal chemistry (2023)
Lívia da Rocha Fernandes, Juliana Romano Lopes, Andressa Francielli Bonjorno, João Lucas Bruno Prates, Cauê Benito Scarim, Jean Leandro Dos Santos
The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors. Viruses 15 (11) (2023)
Guilherme Felipe Dos Santos Fernandes, Cauê Benito Scarim, Seong-Heun Kim, Jingyue Wu, Daniele Castagnolo
Oxazolidinones as versatile scaffolds in medicinal chemistry. RSC medicinal chemistry 14 (5) (2023)
Carlos Henrique Lima Imperador, Cauê Benito Scarim, Priscila Longhin Bosquesi, Juliana Romano Lopes, Augusto Cardinalli Neto, Jeanine Giarolla, Elizabeth Igne Ferreira, Jean Leandro Dos Santos, Chung Man Chin
Resveratrol and Curcumin for Chagas Disease Treatment-A Systematic Review. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Cauê Benito Scarim, Fernando Rogério Pavan
An overview of sulfonamide-based conjugates: Recent advances for tuberculosis treatment. Drug development research 83 (3) (2022)
Cauê Benito Scarim, Fernando Rogério Pavan
Recent advancement in drug development of nitro(NO 2 )-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis. Drug development research 83 (4) (2022)
Cauê Benito Scarim, Francisco Olmo, Elizabeth Igne Ferreira, Chung Man Chin, John M Kelly, Amanda Fortes Francisco
Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi. International journal of molecular sciences 22 (13) (2021)
Cauê Benito Scarim, Cleverton R de Andrade, João A da Rosa, Jean L Dos Santos, Chung M Chin
Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study. International journal of experimental pathology 99 (5) (2018)